Search database
LIST OPTIONS
Filter
8
Filtered Results: 8
Text search: Corum, J.
Featured
Language
Document type
Studies & Reports
4
Resource Platforms
2
Fact sheets
2
Countries / Regions
Germany
1
Chile
1
Latin America and the Carribbean
1
Authors & Publishers
and C. Wonodi
1
and C. Zimmer
1
Argote P., Barhan E., Zukerman Daly S. et al.
1
Corum, J.
1
Jara A., Undurraga E. A. et al
1
Knoll, M.D.
1
Mauder, S.
1
Mauder, S., K. Geffert
1
MEDBOX
1
New York Times
1
NPJ
1
The New York Times
1
World Health Organisation (WHO)
1
Zimmer, C, J. Corum and S. Wee
1
Publication Years
Category
Countries
2
Key Resources
2
Toolboxes
COVID-19
5
TB
1
Health Financing Toolbox
1
 External Link
 Add to my MEDBOX

Coronavirus Variants and Mutations

Corum, J.; and C. Zimmer The New York Times (2021) CC
The NY Times variant tracker is perhaps the most accessible and relevant publication for non-molecular biologists and the general public Each coronavirus contains nearly 30,000 letters of RNA. This genetic information allows the virus to infect cells and hijack them to make new viruses.
 External Link
 Add to my MEDBOX

Coronavirus Vaccine Tracker

Zimmer, C, J. Corum and S. Wee New York Times (2022) CC
 Add to my MEDBOX

Impfung & COVID-19
recommended

Mauder, S., K. Geffert MEDBOX (2021) CC
MEDBOX Issue Brief no. 7, Dec. 2020 Die Impfung gegen die Ausbreitung des SARS-CoV-2-Virus stellt einen Meilenstein in der Bekämpfung der Pandemie dar. Für den Erfolg der Impfung unabdingbar ist eine gute Kommunikation und Aufklärung der Bevölkerung. Im Folgenden sind einige Informationen zur I... more
 External Link
 Add to my MEDBOX

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Jara A., Undurraga E. A. et al (2021) C2
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome c... more
 External Link
 Add to my MEDBOX

Oxford–AstraZeneca COVID-19 vaccine efficacy

Knoll, M.D.; and C. Wonodi (2021) CC
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021 Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
 Add to my MEDBOX

COVID-19 & Vaccination
recommended

Mauder, S. (2021) CC
Issue Brief no.8. January 18,2021 Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies,... more
 External Link
 Add to my MEDBOX

The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America

Argote P., Barhan E., Zukerman Daly S. et al. NPJ (2021) CC
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv... more
 Download  (131)
  View PDF  (129)
 Add to my MEDBOX

Tuberculosis Research Funding Trends 2005-2020

World Health Organisation (WHO) (2021) C_WHO
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge now is to ensure that these commitments are actually met within a global biomedical research ecosystem that... more